Literature DB >> 28418257

Investigating Acquisition Performance on the Orbitrap Fusion When Using Tandem MS/MS/MS Scanning with Isobaric Tags.

Christopher S Hughes1, Victor Spicer2, Oleg V Krokhin2,3, Gregg B Morin1,4.   

Abstract

Methods for isobaric-tagged peptide analysis (e.g., TMT, iTRAQ), such as the synchronous precursor selection (SPS) tandem MS/MS/MS (MS3) approach, enable maintenance of reporter ion accuracy and precision by reducing the ratio compression caused by coisolated precursor ions. However, the decreased throughput of the MS3 approach necessitates careful optimization of acquisition strategies and methods to ensure maximal proteome coverage. We present a systematic analysis of acquisition parameters used to analyze isobaric-tagged peptide samples on current generation Orbitrap mass spectrometer (MS) hardware. In contrast with previously reported works, we demonstrate the limited utility of acquiring reporter ion data in the ion trap analyzer; ion trap acquisition had only a minimal increase in identification depth and reduced quantification precision. We establish that despite the significantly increased scan rate afforded through the use of higher energy collisional dissociation (HCD) in MS3-based ion trap isobaric tag analyses, the reduced quantification precision and reporter ion yields negate the potential benefits in proteome coverage. Lastly, using optimized parameter sets, we further demonstrate the limited utility of the ion trap detector versus the Orbitrap for reporter ion detection in an in-depth analysis of a complex proteome sample. Together, these data will serve as a valuable resource to researchers undertaking analysis on current generation Orbitrap instrumentation with isobaric tags.

Entities:  

Keywords:  CID; HCD; MS/MS/MS analysis; Orbitrap; ion trap; isobaric labeling; multinotch isolation; quantitative proteomics; synchronous precursor selection; tandem mass tagging

Mesh:

Substances:

Year:  2017        PMID: 28418257     DOI: 10.1021/acs.jproteome.7b00091

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  8 in total

1.  Comparative Analysis of Quantitative Mass Spectrometric Methods for Subcellular Proteomics.

Authors:  Abla Tannous; Marielle Boonen; Haiyan Zheng; Caifeng Zhao; Colin J Germain; Dirk F Moore; David E Sleat; Michel Jadot; Peter Lobel
Journal:  J Proteome Res       Date:  2020-03-05       Impact factor: 4.466

2.  TKO6: A Peptide Standard To Assess Interference for Unit-Resolved Isobaric Labeling Platforms.

Authors:  Joao A Paulo; Jose Navarrete-Perea; Sanjukta Guha Thakurta; Steven P Gygi
Journal:  J Proteome Res       Date:  2018-12-06       Impact factor: 4.466

3.  Quantitative Proteome and Phosphoproteome Analyses of Streptomyces coelicolor Reveal Proteins and Phosphoproteins Modulating Differentiation and Secondary Metabolism.

Authors:  Beatriz Rioseras; Pavel V Shliaha; Vladimir Gorshkov; Paula Yagüe; María T López-García; Nathaly Gonzalez-Quiñonez; Sergey Kovalchuk; Adelina Rogowska-Wrzesinska; Ole N Jensen; Angel Manteca
Journal:  Mol Cell Proteomics       Date:  2018-05-21       Impact factor: 5.911

4.  Evaluating Spatiotemporal Dynamics of Phosphorylation of RNA Polymerase II Carboxy-Terminal Domain by Ultraviolet Photodissociation Mass Spectrometry.

Authors:  Edwin E Escobar; Mukesh Kumar Venkat Ramani; Yan Zhang; Jennifer S Brodbelt
Journal:  J Am Chem Soc       Date:  2021-05-31       Impact factor: 16.383

5.  Quantitative Proteomics Reveals the Dynamic Pathophysiology Across Different Stages in a Rat Model of Severe Traumatic Brain Injury.

Authors:  Weikang Luo; Zhaoyu Yang; Wei Zhang; Dan Zhou; Xiaohang Guo; Shunshun Wang; Feng He; Yang Wang
Journal:  Front Mol Neurosci       Date:  2022-01-25       Impact factor: 5.639

6.  Integrative analysis of non-small cell lung cancer patient-derived xenografts identifies distinct proteotypes associated with patient outcomes.

Authors:  Shideh Mirhadi; Shirley Tam; Quan Li; Nadeem Moghal; Nhu-An Pham; Jiefei Tong; Brian J Golbourn; Jonathan R Krieger; Paul Taylor; Ming Li; Jessica Weiss; Sebastiao N Martins-Filho; Vibha Raghavan; Yasin Mamatjan; Aafaque A Khan; Michael Cabanero; Shingo Sakashita; Kugeng Huo; Sameer Agnihotri; Kota Ishizawa; Thomas K Waddell; Gelareh Zadeh; Kazuhiro Yasufuku; Geoffrey Liu; Frances A Shepherd; Michael F Moran; Ming-Sound Tsao
Journal:  Nat Commun       Date:  2022-04-05       Impact factor: 14.919

7.  Proteomic analysis of archival breast cancer clinical specimens identifies biological subtypes with distinct survival outcomes.

Authors:  Karama Asleh; Gian Luca Negri; Sandra E Spencer Miko; Shane Colborne; Christopher S Hughes; Xiu Q Wang; Dongxia Gao; C Blake Gilks; Stephen K L Chia; Torsten O Nielsen; Gregg B Morin
Journal:  Nat Commun       Date:  2022-02-16       Impact factor: 14.919

8.  Y-box binding protein-1 is crucial in acquired drug resistance development in metastatic clear-cell renal cell carcinoma.

Authors:  Ninadh M D'Costa; Matthew R Lowerison; Peter A Raven; Zheng Tan; Morgan E Roberts; Raunak Shrestha; Matthew W Urban; Cesar U Monjaras-Avila; Htoo Zarni Oo; Antonio Hurtado-Coll; Claudia Chavez-Munoz; Alan I So
Journal:  J Exp Clin Cancer Res       Date:  2020-02-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.